Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:535-544
Published online before print July 2, 2007, doi: 10.1161/CIRCULATIONAHA.107.689471
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/5/535    most recent
CIRCULATIONAHA.107.689471v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xuan, Y.-T.
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xuan, Y.-T.
Right arrow Articles by Bolli, R.
Related Collections
Right arrow Ischemic biology - basic studies

(Circulation. 2007;116:535-544.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Endothelial Nitric Oxide Synthase Plays an Obligatory Role in the Late Phase of Ischemic Preconditioning by Activating the Protein Kinase C{epsilon}–p44/42 Mitogen-Activated Protein Kinase–pSer-Signal Transducers and Activators of Transcription1/3 Pathway

Yu-Ting Xuan, PhD; Yiru Guo, MD; Yanqing Zhu, MD; Ou-Li Wang, MD; Gregg Rokosh, PhD; Roberto Bolli, MD

From the Institute of Molecular Cardiology, University of Louisville, Louisville, Ky.

Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292 (e-mail rbolli{at}louisville.edu); or Yu-Ting Xuan, PhD, Division of Cardiology, University of Louisville, Louisville, KY 40292 (e-mail ytxuan01@louisville.edu).

Received January 9, 2007; accepted May 29, 2007.

Background— The role of endothelial nitric oxide synthase (eNOS) in ischemic preconditioning (PC) and cardioprotection is poorly understood. We addressed this issue using a genetic, rather than pharmacological, approach.

Methods and Results— In the nonpreconditioned state, eNOS–/– mice exhibited infarct sizes similar to those of wild-type mice. A sequence of six 4-minute coronary occlusion/4-minute reperfusion cycles (ischemic PC) induced late PC in wild-type mice; genetic deletion of eNOS abrogated the cardioprotection induced by late PC. In wild-type mice, ischemic PC induced membranous translocation of protein kinase C (PKC){epsilon} and an increase in pSer-MEK-1/2 and pTyr-p44/42 mitogen-activated protein kinase, nuclear pSer-signal transducers and activators of transcription (STAT)1 and pSer-STAT3, and nuclear STAT1/3 DNA binding activity, followed by upregulation of cyclooxygenase-2 protein and activity 24 hours later. All of these changes were abrogated in eNOS–/– mice. The NO donor diethylenetriamine/NO recapitulated the effects of ischemic PC.

Conclusions— In contrast to previous reports, we found that basal eNOS activity does not modulate infarct size in the nonpreconditioned state. However, eNOS is obligatorily required for the development of the cardioprotective effects of late PC and acts as the trigger of this process by activating the PKC{epsilon}-MEK-1/2-p44/42 mitogen-activated protein kinase pathway, leading to Ser-727 phosphorylation of STAT1 and STAT3 and consequent upregulation of STAT-dependent genes such as cyclooxygenase-2. The effects of eNOS-derived NO are reproduced by exogenous NO (NO donors), implying that nitrates can upregulate cardiac cyclooxygenase-2.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Matsuhisa, H. Otani, T. Okazaki, K. Yamashita, Y. Akita, D. Sato, A. Moriguchi, H. Imamura, and T. Iwasaka
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2473 - H2479.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D.T. Costa, S. V. Pierre, M. V. Cohen, J. M. Downey, and K. D. Garlid
cGMP signalling in pre- and post-conditioning: the role of mitochondria
Cardiovasc Res, January 15, 2008; 77(2): 344 - 352.
[Abstract] [Full Text] [PDF]